Axis Spine Technologies has secured a U.S. Department of Veterans Affairs contract that makes its Axis-ALIF system available across VA facilities nationwide. For a company founded in 2017 and focused on anterior spine surgery, the award is more than a commercial milestone. It is a meaningful validation point for a platform built around intraoperative flexibility and modular implant design.
At the center of the story is Axis-ALIF, a modular anterior lumbar interbody fusion system that is assembled in vivo rather than inserted as a single monobloc cage. According to the FDA 510(k) summary, the implant consists of two endplates and a central core, with different shapes and sizes intended to help the final construct better match patient anatomy and pathology. That modular architecture is the defining feature of the system and the reason Axis has tried to position it as something more than just another ALIF cage.
The original FDA clearance for Axis-ALIF came in May 2020. Axis later announced an additional FDA 510(k) clearance in 2021 covering standalone use and extended applications, including lordotic options up to 40 degrees and coronally tapered endplates up to 20 degrees. In a market crowded with interbody implants that often differ more in marketing language than in surgical philosophy, Axis has chosen to compete on configurability, correction potential, and the promise of a more anatomy-matched construct.
That positioning is consistent with the company’s broader strategy. Axis describes itself as a UK-based medtech company focused on improving anterior spinal surgery through a proprietary modular cage platform spanning ALIF, OLIF, and lateral approaches, together with an advanced retractor system. The company’s early public messaging has repeatedly emphasized that its technology is designed to give surgeons greater correction capability while preserving procedural flexibility.
The clinical argument for modularity is also starting to move beyond theory. In 2025, a study published in Clinical Biomechanics reported that three-part modular cages may reduce insertion forces, minimize endplate damage, and allow greater lordotic correction compared with conventional monobloc designs. That does not settle the long-term clinical debate, because spine never makes life that easy, but it does give Axis something more substantial than the usual innovation language that floods this segment.
From the VA perspective, the appeal is easy to understand. A system that can be stocked as a platform and then configured intraoperatively offers flexibility across surgeons, anatomies, and case requirements. For Axis Spine Technologies, the contract broadens access to the U.S. market and gives the company a stronger foothold at a time when modularity, alignment, and implant versatility are becoming more central to the ALIF conversation.
About Axis Spine Technologies
Axis Spine Technologies is a UK/USA-based medical device company founded in 2017 that develops modular, patient-specific spinal implants aimed at improving Anterior Lumbar Interbody Fusion (ALIF) procedures. Their technology focuses on “endplate protection” through a modular design, allowing smaller, low-force insertion for better spinal alignment and reduced subsidence.
Website: https://www.axisspinetech.com/
###
Legal Disclaimer:
Content published on SPINEMarketGroup (thespinemarketgroup.com) is provided for informational purposes only and on an “as is” basis, without warranties of any kind. We do not guarantee the accuracy, completeness, legality, or reliability of any information, images, videos, links, or third-party materials featured on the site. Any views or claims expressed in contributed content or press releases belong to their respective authors or sources. For copyright concerns, factual corrections, or content-related complaints, please contact us directly for review.